Mario Paolo Colombo
#123,385
Most Influential Person Now
Researcher
Mario Paolo Colombo's AcademicInfluence.com Rankings
Mario Paolo Colombocomputer-science Degrees
Computer Science
#5064
World Rank
#5350
Historical Rank
Computational Linguistics
#617
World Rank
#629
Historical Rank
Machine Learning
#1200
World Rank
#1220
Historical Rank
Artificial Intelligence
#1432
World Rank
#1461
Historical Rank

Download Badge
Computer Science
Mario Paolo Colombo's Degrees
- PhD Computer Science ETH Zurich
Similar Degrees You Can Earn
Why Is Mario Paolo Colombo Influential?
(Suggest an Edit or Addition)Mario Paolo Colombo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards (2016) (1817)
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. (2006) (863)
- The terminology issue for myeloid-derived suppressor cells. (2007) (720)
- Interleukin-12 in anti-tumor immunity and immunotherapy. (2002) (670)
- Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo (1996) (597)
- Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. (2005) (556)
- IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice1 (2003) (533)
- p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. (2006) (469)
- The intriguing role of polymorphonuclear neutrophils in antitumor reactions. (2001) (437)
- Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. (2005) (432)
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection (2008) (387)
- Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy (2007) (381)
- Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody (2002) (376)
- CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. (2008) (374)
- DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2 (2000) (373)
- Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. (2007) (364)
- The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. (2008) (360)
- Classification of current anticancer immunotherapies (2014) (357)
- Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. (1999) (352)
- Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice (1998) (347)
- Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. (2012) (334)
- Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. (2003) (324)
- Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. (2007) (317)
- Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo (1991) (315)
- Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. (2005) (297)
- Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade (2018) (287)
- Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. (2006) (281)
- Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. (2006) (268)
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? (1994) (266)
- Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice (2001) (258)
- Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes (1994) (257)
- The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference * (2011) (245)
- The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. (1999) (221)
- HOXB7 constitutively activates basic fibroblast growth factor in melanomas (1996) (218)
- Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. (1992) (215)
- Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response (1999) (215)
- Amount of interleukin 12 available at the tumor site is critical for tumor regression. (1996) (207)
- Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis (2010) (204)
- Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. (2009) (196)
- Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 (2010) (194)
- Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. (1998) (193)
- Cytokines, tumour-cell death and immunogenicity: a question of choice. (1997) (191)
- Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. (1997) (185)
- Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma (1993) (184)
- Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. (2008) (172)
- IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice1 (2004) (170)
- Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor α, Granulocyte-Macrophage Colony-stimulating Factor, and γ-Interferon Gene or Admixed with Conventional Adjuvants (1994) (168)
- Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. (1999) (159)
- Cancer immunotherapy based on killing of Salmonella-infected tumor cells. (2005) (158)
- IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk1 (2001) (155)
- Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells (2006) (152)
- CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. (2010) (149)
- HOXB7: a key factor for tumor-associated angiogenic switch. (2001) (148)
- Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. (2000) (145)
- RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis. (2015) (144)
- Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma (2003) (143)
- An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. (1994) (140)
- CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes (1995) (137)
- Single Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation. (2019) (137)
- Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. (2006) (137)
- TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site (2016) (136)
- Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. (2003) (136)
- Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo (2003) (134)
- Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death. (2010) (129)
- Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors (2019) (129)
- CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell‐produced IL‐2 (2005) (122)
- Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. (2011) (122)
- Consensus nomenclature for CD8+ T cell phenotypes in cancer (2015) (118)
- Cell therapy: achievements and perspectives. (1999) (116)
- The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment (2019) (113)
- Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. (2013) (112)
- Molecular mechanisms of CD99-induced caspase-independent cell death and cell–cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators (2004) (112)
- Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. (2019) (111)
- Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. (2005) (108)
- Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. (2005) (106)
- In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type (2005) (104)
- Expression of cytokine genes, including IL‐6, in human malignant melanoma cell lines (1992) (100)
- Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro (1993) (100)
- CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine1 (2006) (99)
- Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. (1996) (98)
- Osteopontin shapes immunosuppression in the metastatic niche. (2014) (98)
- Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. (1996) (97)
- Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. (2014) (95)
- Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence (1998) (94)
- Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. (1998) (91)
- Antitumor vaccination: where we stand. (2000) (91)
- Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. (2007) (89)
- Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. (1992) (88)
- Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. (1996) (87)
- Immunoprevention of cancer: is the time ripe? (2000) (87)
- Triggering CD40 on endothelial cells contributes to tumor growth (2006) (85)
- Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity123 (2014) (79)
- Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. (2010) (77)
- In vitro anti‐tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5 (1993) (77)
- Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. (1991) (76)
- Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. (2016) (76)
- Interleukin-12 as an adjuvant for cancer immunotherapy. (1999) (74)
- Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors (2011) (74)
- IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions. (2013) (74)
- Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. (1996) (74)
- Enhanced Efficacy of Tumor Cell Vaccines Transfected with Secretable hsp70 (2004) (73)
- The Aryl Hydrocarbon Receptor Modulates Acute and Late Mast Cell Responses (2012) (71)
- Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. (1997) (71)
- Multiple molecular alterations in mouse lung tumors (1992) (71)
- Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe (2018) (70)
- Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. (1999) (70)
- OX40 Ligand-Transduced Tumor Cell Vaccine Synergizes with GM-CSF and Requires CD40-Apc Signaling to Boost the Host T Cell Antitumor Response1 (2003) (69)
- Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody. (1998) (69)
- A non‐redundant role for OX40 in the competitive fitness of Treg in response to IL‐2 (2010) (68)
- CD99 acts as an oncosuppressor in osteosarcoma. (2006) (68)
- Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiation (1999) (68)
- Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. (1993) (67)
- Interleukin 12 gene therapy of MHC-negative murine melanoma metastases. (1998) (65)
- SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. (2011) (65)
- Role of PLZF in melanoma progression (2004) (64)
- Interferon γ–independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4+ T Cells and Granulocyte/Macrophage Colony–stimulating Factor (1998) (64)
- The Role of Mast Cells in Molding the Tumor Microenvironment (2015) (64)
- IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. (1995) (64)
- Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. (2000) (63)
- Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells. (1999) (62)
- Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice (2005) (61)
- Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line (1990) (61)
- ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells (2017) (61)
- Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice (2011) (60)
- In vivo correction of genetic defects of monocyte/ macrophages using attenuated Salmonella as oral vectors for targeted gene delivery (2000) (60)
- Mast Cells Boost Myeloid-Derived Suppressor Cell Activity and Contribute to the Development of Tumor-Favoring Microenvironment (2014) (60)
- Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs (2020) (59)
- Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. (2017) (58)
- IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. (1999) (58)
- Salmonella vaccine carrier strains: effective delivery system to trigger anti‐tumor immunity by oral route (1999) (58)
- Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis (2014) (57)
- The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway (2013) (56)
- c-fes expression in ontogenetic development and hematopoietic differentiation. (1994) (56)
- The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. (1998) (56)
- Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes (1993) (56)
- Mast cells, basophils and eosinophils: From allergy to cancer. (2018) (55)
- A B7‐1‐transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes (1995) (54)
- Cytokine gene transduction in the immunotherapy of cancer. (1997) (54)
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C (2013) (53)
- The dark side of mast cell-targeted therapy in prostate cancer. (2012) (53)
- Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress (2013) (53)
- The defined attenuated Listeria monocytogenes Δmpl2 mutant is an effective oral vaccine carrier to trigger a long‐lasting immune response against a mouse fibrosarcoma (1997) (53)
- The bone marrow stroma in hematological neoplasms—a guilty bystander (2011) (52)
- Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity (2013) (52)
- Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. (1997) (51)
- IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases. (1998) (51)
- The high lysability by lak cells of colon‐carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM‐1, LFA‐3, NCA and a less‐differentiated phenotype (1991) (51)
- Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. (2012) (50)
- Genetic modification of a carcinoma with the IL‐4 gene increases the influx of dendritic cells relative to other cytokines (1997) (49)
- Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors (2017) (49)
- Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional a (1994) (48)
- Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. (2019) (48)
- Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer (2021) (48)
- Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin. (1995) (47)
- Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability (1997) (47)
- Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells (2002) (47)
- Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen. (2017) (46)
- Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15. (2002) (45)
- IFN‐γ‐independent synergistic effects of IL‐12 and IL‐15 induce anti‐tumor immune responses in syngeneic mice (2002) (45)
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells. (2019) (45)
- Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. (1994) (44)
- Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. (2005) (44)
- Peripheral regulatory T cells and serum transforming growth factor‐&bgr;: Relationship with clinical response to infliximab in Crohn's disease (2010) (44)
- Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. (2014) (44)
- Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma (2011) (43)
- CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling (2016) (42)
- Intratumor OX40 stimulation inhibits IRF1 expression and IL‐10 production by Treg cells while enhancing CD40L expression by effector memory T cells (2011) (41)
- Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer (2018) (40)
- Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy. (1993) (39)
- Liver stiffness measurement reliability and main determinants of point shear‐wave elastography in patients with chronic liver disease (2016) (39)
- Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin (2012) (39)
- Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors. (1992) (38)
- Matricellular proteins at the crossroad of inflammation and cancer. (2008) (38)
- IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS (1983) (37)
- An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines (1995) (37)
- In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. (2004) (37)
- IL‐1α gene‐transfected human melanoma cells increase tumor‐cell adhesion to endothelial cells and their retention in the lung of nude mice (1996) (37)
- Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis. (2010) (36)
- CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin (2014) (35)
- SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias. (2015) (35)
- CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2† (2013) (35)
- Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in Mice1 (2002) (35)
- Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer (2018) (35)
- Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. (1993) (35)
- B7.1 gene transduction of human renal‐cell‐carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells (1996) (34)
- CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling (2016) (34)
- Intralesional Injection of Adenovirus Encoding CC Chemokine Ligand 16 Inhibits Mammary Tumor Growth and Prevents Metastatic-Induced Death after Surgical Removal of the Treated Primary Tumor1 (2004) (34)
- SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities (2019) (34)
- Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies (2014) (33)
- Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis (2012) (32)
- Mast Cells Control the Expansion and Differentiation of IL-10–Competent B Cells (2014) (32)
- Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS–Istituto Nazionale dei Tumori di Milano (2020) (32)
- In vitro detection of cell‐mediated immunity to individual tumor‐specific antigens of chemically induced BALB/c fibrosarcomas (1983) (32)
- Human melanoma cells express a functional interleukin‐2 receptor (1993) (31)
- Different requirements for α‐galactosylceramide and recombinant IL‐12 antitumor activity in the treatment of C‐26 colon carcinoma hepatic metastases (2001) (31)
- Overexpression of protectin (CD59) down‐modulates the susceptibility of human melanoma cells to homologous complement (2000) (31)
- Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study. (1994) (31)
- Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. (2005) (31)
- SCD5‐induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B (2015) (31)
- Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen (2000) (30)
- The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses. (2011) (30)
- Somatic gene therapy of human melanoma: preclinical studies and early clinical trials. (1995) (29)
- Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments (2017) (29)
- Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. (2005) (29)
- Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M. (1995) (29)
- Endogenous retroviruses lead to the expression of a histocompatibility antigen detectable by skin graft rejection. (1987) (29)
- Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma (1997) (29)
- Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens. (1987) (29)
- Hepatitis C in haemophilia: lights and shadows (2004) (28)
- Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. (2003) (26)
- The good and bad of targeting cancer-associated extracellular matrix. (2017) (26)
- 755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICS (2013) (26)
- Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. (2012) (25)
- Immunotherapy I: Cyclosine gene transfer strategies (1996) (25)
- Cross‐reactions between tumor cells and allogeneic normal tissues. inhibition of a syngeneic lymphoma outgrowth in h‐2 and non‐h‐2 alloimmune balb/c mice (1982) (25)
- Immune Checkpoint Ligand Reverse Signaling: Looking Back to Go Forward in Cancer Therapy (2019) (25)
- Convergences and Divergences of Thymus- and Peripherally Derived Regulatory T Cells in Cancer (2013) (25)
- Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism. (2008) (24)
- Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability (1997) (24)
- Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine (1999) (24)
- Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma. (2003) (24)
- Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. (2017) (23)
- Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors. (1996) (23)
- Regulated Expression of miR-155 is Required for iNKT Cell Development (2015) (23)
- Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial. (2019) (22)
- Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth. (2015) (22)
- HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1. (2003) (22)
- DNA threads released by activated CD4+ T lymphocytes provide autocrine costimulation (2019) (22)
- Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti–Salmonella typhimurium immunity (2008) (22)
- Polyps wrap mast cells and Treg within tumorigenic tentacles. (2009) (21)
- Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis (2004) (21)
- Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness. (2010) (21)
- Immunometabolic Status of COVID-19 Cancer Patients (2020) (20)
- Ledipasvir/Sofosbuvir for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 Hcv Infection (2016) (20)
- Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes (2001) (19)
- IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. (1996) (19)
- Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients (2004) (19)
- 85 Five years of sequential LAM TO LAM+ADV therapy suppresses HBV replication in most HBeAg-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma (2006) (19)
- Cytokine-based gene therapy of human tumors. An overview. (1996) (19)
- 98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B (2010) (18)
- Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells (2014) (18)
- Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis. (2002) (18)
- Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells. (1994) (18)
- Anti‐tumor activity of CpG‐ODN aerosol in mouse lung metastases (2013) (18)
- Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4‐ or an IL5‐transduced tumour (1998) (18)
- Localization of growth arrest-specific genes on mouse Chromosomes 1, 7, 8, 11, 13, and 16 (2004) (17)
- The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms (2021) (17)
- A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas (2020) (17)
- Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype (2020) (16)
- cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells (2018) (16)
- Matricellular proteins tune myeloid‐derived suppressor cell recruitment and function in breast cancer (2017) (16)
- Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces (2020) (16)
- 6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma (2011) (16)
- OC7 AN IL28B POLYMORPHISM PREDICTS PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 4 (2011) (16)
- Apoptosis induced by HIV‐gp120 in a Th1 clone involves the generation of reactive oxygen intermediates downstream CD95 triggering (1997) (15)
- A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy (2019) (15)
- Passive adoptive immunotherapy of low‐immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes (1984) (15)
- Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas (2012) (15)
- DNA vaccination against the ovarian carcinoma-associated antigen folate receptor α (FRα) induces cytotoxic T lymphocyte and antibody responses in mice (1999) (15)
- Immunotherapy I: Cytokine gene transfer strategies (2004) (14)
- IL‐10‐producing B cells are characterized by a specific methylation signature (2019) (13)
- A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype. (1995) (13)
- Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice. (2000) (13)
- HOXB 7 : A Key Factor for Tumor-associated Angiogenic Switch 1 (2001) (13)
- Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes. (1994) (13)
- Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts. (1991) (13)
- MicroRNA-221/-222 pathway controls melanoma progression (2008) (13)
- IL-4 gene transfer for the treatment of experimental gliomas. (1998) (12)
- Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy (2009) (12)
- Lymphotoxin gene expression by melanocytes and melanoma cell lines and persistence of unspliced mRNA (1993) (12)
- Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells. (1998) (12)
- Liver Follicular Helper T-Cells Predict the Achievement of Virological Response following Interferon-Based Treatment in HCV-Infected Patients (2012) (12)
- ORAL COMMUNICATIONSOC.07.1 2-YEAR EFFECTIVENESS AND SAFETY OF TENOFOVIR IN 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTICE (2012) (12)
- Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions. (1994) (12)
- Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity. (2018) (11)
- 930 HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B (2009) (11)
- Erratum: In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5 (Int. J. Cancer, 54, 8-15 (1993)) (1993) (11)
- Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers (2015) (11)
- Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment (2019) (11)
- In vivo reexpression of H-2 antigens in B16 melanoma cells. (1985) (11)
- 742TiPPHASE 3 RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF CABOZANTINIB (XL184) VS PLACEBO IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA WHO HAVE RECEIVED PRIOR SORAFENIB (CELESTIAL) (NCT01908426). (2014) (11)
- Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma (2005) (11)
- T Cell Costimulation Blockade Blunts Age-Related Heart Failure (2020) (11)
- Isolation and mapping to 17p12-13 of the human homologous of the murine growth arrest specific Gas-3 gene. (1992) (11)
- 829 EFFECTIVENESS OF HEPATITIS C VIRUS TREATMENT IN REAL-LIFE PRACTICE: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY IN ITALY (PROBE) (2008) (10)
- 522 MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFILE OF ENTECAVIR MONOTHERAPY IN 418 NUC-NAÏVE PATIENTS WITH CHRONIC HEPATITIS B: A 4-YEAR FIELD PRACTICE, MULTICENTER STUDY (2012) (10)
- C-EDGE IBLD: Efficacy and Safety of Elbasvir/Grazoprevir (EBR/GZR) in Subjects with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders (2016) (10)
- HIV/gp120 and PMA/ionomycin induced apoptosis but not activation induced cell death require PKC for Fas‐L upregulation (1998) (10)
- Separation of Dual Oxidase 2 and Lactoperoxidase Expression in Intestinal Crypts and Species Differences May Limit Hydrogen Peroxide Scavenging During Mucosal Healing in Mice and Humans. (2017) (10)
- Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs. (2019) (10)
- Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β (2016) (10)
- T-8 Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: high efficacy and favorable safety profile over 3 years of treatment (2012) (10)
- F.N.16 EFFECTIVENESS OF ENTECAVIR FOR NUC-NAIVE, HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: A 2-YEAR MULTICENTER COHORT STUDY IN 311 PATIENTS (2010) (9)
- CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response (2004) (9)
- Healthy and tumoral tissue resistivity in wild-type and sparc–/– animal models (2016) (9)
- Perspectives for the gene therapy of malignant gliomas by suicide gene transfer. (1997) (9)
- Sequence of human GAS3/PMP22 full-length cDNA. (1993) (9)
- DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice. (1999) (9)
- Carcinomas in Transgenic BALB / c Mice Carcinogenesis Than Transplantable p 185 More Effectively Inhibits DNA Vaccination Against Rat Her-2 / Neu Musiani and (2000) (8)
- Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity (2019) (8)
- Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years (2006) (8)
- Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines. (2002) (8)
- Transarterial embolization with microspheres in the treatment of monofocal HCC. (2009) (8)
- On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence? (2017) (8)
- Antibody‐mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities (2017) (8)
- Myeloid cell heterogeneity in lung cancer: implication for immunotherapy (2021) (7)
- Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis (2016) (7)
- Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study (2019) (7)
- P1119 EARLY VIRAL KINETICS DO NOT PREDICT TREATMENT OUTCOME WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 24 WEEKS IN HCV GENOTYPE 2/3 PATIENTS IN THE VALENCE TRIAL (2014) (7)
- 14 A DRUG TRANSPORTER GENE POLYMORPHISM PREDICTS RENAL TUBULAR TOXICITY IN PATIENTS WITH CHRONIC HEPATITIS B ON LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION (2010) (7)
- CD 99 triggering induces methuosis of Ewing sarcoma cells through IGF-1 R / RAS / Rac 1 signaling (2018) (7)
- P.04.7 A MORPHOMETRIC AND IMMUNOHISTOCHEMICAL STUDY TO ASSESS THE BENEFIT OF AN SVR IN HCV CIRRHOTIC PATIENTS (2012) (7)
- Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer (2017) (7)
- Expression of a growth arrest specific gene (gas‐6) during liver regeneration: Molecular mechanisms and signalling pathways (1994) (7)
- 696 ADD ON ADEFOVIR PREVENTS THE EMERGENCE OF ADV RESISTANCE IN LAMIVUDINE-RESISTANT PATIENTS: A 4-YEAR STUDY (2008) (7)
- In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cells (1999) (7)
- Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer (2021) (7)
- Laser oncology in Italy: experimental research and clinical applications at the National Cancer Institute, Milan (1983) (7)
- 1009 EFFECTIVENESS OF ENTECAVIR FOR NUC-NAIVE, HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: A 2-YEAR MULTICENTER COHORT STUDY IN 311 PATIENTS (2010) (7)
- 806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTION (2013) (6)
- Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. (2001) (6)
- 44 The long-term outcome of HBeAg-Negative patients with cirrhosis treated with lamivudine monotherapy: A 5-year prospective cohort study (2004) (6)
- 399 PNPLA3 I148M AFFECTS LIVER STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS B (2013) (6)
- Adoptive immunotherapy of cancer with immune and activated lymphocytes: Experimental and clinical studies (1986) (6)
- Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: Characterization of the effector population and evidence for the role of the host's non-T cells (2004) (6)
- Removal of the Treated Primary Tumor Metastatic-Induced Death after Surgical Mammary Tumor Growth and Prevents Encoding CC Chemokine Ligand 16 Inhibits Intralesional Injection of Adenovirus (2004) (6)
- 18 DRUG TRANSPORTER GENE POLYMORPHISM PREDICTS RENAL TUBULAR TOXICITY IN PATIENTS WITH CHRONIC HEPATITIS B ON LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION (2010) (6)
- Introduction: Cytokines and Cancer (2002) (6)
- Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects. (2022) (6)
- Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes. (1988) (6)
- Innovative Therapy, Monoclonal Antibodies and Beyond. (2017) (6)
- Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors (2022) (6)
- Ava I RFLP at the gas-1 locus on mouse chromosome 12. (1989) (6)
- 523 ADD-ON PEG-IFN IMPROVES HBSAG KINETICS IN PATIENTS LONG-TERM FULLY SUPPRESSED BY NUCLEOS(T)IDE ANALOGS (2012) (5)
- SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model (2022) (5)
- Inheritance of a mutant histocompatibility gene and a new mammary tumor virus genome in the B6.KH-84 mouse strain (2004) (5)
- Cytokine gene transfer in tumor cells as an approach to antitumor therapy (1992) (5)
- Mechanisms for Tumor Killing and Use Fas / Fas Ligand-Independent CTL Clones Resist Fas Ligand-Induced Apoptosis + and CD 8 + Human Melanoma-Reactive CD 4 (1998) (5)
- 730 PEGBELIVER STUDY: HBSAG DECLINE AT WEEK 24 OF EXTENDED PEGINTERFERON ALFA-2A (PEG-IFNα-2A) THERAPY IS SIGNIFICANTLY ASSOCIATED WITH POST-TREATMENT RESPONSE IN HBEAG-NEGATIVE GENOTYPE D PATIENTS (2011) (5)
- [496] SIX YEARS OF ON DEMAND LAM±ADV COMBINATION THERAPY SIGNIFICANTLY REDUCES THE DEVELOPMENT AND PROGRESSION OF ESOPHAGEAL VARICES IN PATIENTS WITH HBeAg-NEGATIVE CIRRHOSIS (2007) (5)
- F-33 High prevalence of reduced bone mineral density in patients with chronic hepatitis B under nucleos(t)ides analogues treatment (2011) (5)
- OC-13 ADVANCE study: Final results of the phase III trial with telaprevir in combination with PEG-IFN and RBV in treatment-naïve genotype 1 HCV (2011) (5)
- Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: Do animal studies really support clinical trials? (1995) (5)
- P1032 LOW ACCURACY OF NON-INVASIVE TESTS FOR ASSESSING RESIDUAL CIRRHOSIS IN HEPATITIS C PATIENTS WITH A SUSTAINED VIROLOGICAL RESPONSE (2014) (5)
- Tumor-cell-targeted cytokine gene therapy. (1991) (5)
- Guidelines for the treatment of chronic viral hepatitis (1997) (5)
- 94 Prospective randomised trial on IFN-therapy for the secondary prevention of HCC recurrence after curative resection in HCV related cirrhosis. Preliminary report (2004) (5)
- Retroviral heterogeneity in mouse lymphomas. (1988) (5)
- Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network. (2016) (5)
- Expression of a growth arrest specific gene (gas-1) in transformed cells. (1992) (5)
- Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma (2021) (5)
- Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1) (2004) (5)
- Modulation of PD-1/PD-L1 axis in myeloid-derived suppressor cells by anti-cancer treatments. (2021) (5)
- Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis (2021) (5)
- 777 INCIDENCE AND CLINICAL CONSEQUENCES OF REDUCED TUBULAR PHOSPHATE RE-ABSORPTION (TmPO4/GFR) IN NAÏVE CHRONIC HEPATITIS B PATIENTS TREATED WITH TENOFOVIR: A TWO-YEAR FIELD STUDY (2013) (4)
- The ins and outs of osteopontin (2015) (4)
- CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy (2022) (4)
- Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells. (1983) (4)
- 524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTS (2012) (4)
- Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain (2021) (4)
- [57] 3 YEARS OF ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY MINIMIZES THE RISK OF GENOTYPIC RESISTANCE TO ADV IN LAM RESISTANT PATIENTS (2007) (4)
- OC.09.6: GENETIC VARIATION IN IL28B POLYMORPHISM MAY PREDICT HBSAG CLEARANCE IN GENOTYPE D, HBEAG NEGATIVE PATIENTS TREATED WITH INTERFERON ALFA (2011) (4)
- Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer (2013) (4)
- Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy (2021) (4)
- OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis (2018) (4)
- Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients (2020) (4)
- Immunogenicity of a yeast‐recombinant hepatitis B vaccine in high‐risk children (1989) (4)
- 315 I148M PNPLA3 POLYMORPHISM IS ASSOCIATED WITH CLINICAL FEATURES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2012) (4)
- CHANGES IN LIVER STIFFNESS DURING ENTECAVIR THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B (2009) (4)
- RORC 1 Regulates Tumor-Promoting ‘ ‘ Emergency ’ ’ Granulo-Monocytopoiesis Graphical Abstract Highlights (3)
- 1369 TRANSIENT ELASTOGRAPHY IN ACUTE ALCOHOLIC HEPATITIS AND DURING FOLLOW UP: A SINGLE-INSTITUTION EXPERIENCE (2012) (3)
- Control of human melanoma growth in nude mice by autologous allo‐activated peripheral blood lymphocytes (1986) (3)
- SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis (2020) (3)
- Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation (2021) (3)
- 506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS (2013) (3)
- OC-26 Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the Italian telaprevir early access program (2013) (3)
- 291 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY (2010) (3)
- T-25 Impact of insulin resistance on antiviral efficacy of telaprevir-based regimen in treatment-naïve genotype 1 HCV: Results from C208 sub-analysis (2011) (3)
- Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes. (1987) (3)
- Chemoembolization with epirubicin drug-eluting beads (DEB-TACE) to treat early and intermediate hepatocellular carcinoma. (2010) (3)
- The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward (2008) (3)
- Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended (2021) (3)
- Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients (2008) (3)
- Diagnostic value of Lens culinaris agglutinin isoform 3 fraction (AFP-L3%) and des-gamma-carboxy prothrombin (DCP) for the diagnosis of hepatocellular carcinoma in cirrhotic patients. (2010) (3)
- Release of IFN-γ by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells. (2022) (3)
- Circulating and tumor-associated neutrophil subtypes discriminate hyperprogressive disease (HPD) from conventional progression (PD) upon immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients (pts) and in vivo models. (2020) (3)
- Is GPNMB the Achilles' Heel of Mo-MDSC While Marking Their Suppressive Activity? (2018) (3)
- P1206 ITPA GENE VARIANTS AND ANEMIA DURING TELAPREVIR/PEGINTERFERON/RIBAVIRIN COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION (2014) (3)
- 382 CHANGES IN LIVER STIFFNESS DURING ENTECAVIR THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B (2009) (3)
- Strain polymorphism and tentative mapping of mouse ornithine decarboxylase. (1988) (2)
- Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start (2017) (2)
- Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B (2008) (2)
- 545 DECLINE OF BONE MINERAL DENSITY DURING LONG-TERM NUCLEOS(T)IDE ANALOG THERAPY: A LONGITUDINAL COHORT STUDY OF 135 PATIENTS WITH CHRONIC HEPATITIS B (2012) (2)
- Low body mass index (BMI) predicts discordance between transient elastography (TE) and liver biopsy (LB) assessment of liver fibrosis (2007) (2)
- Interferon-γ-Dependent Inflammatory Signature in Acute Myeloid Leukemia Cells Is Able to Shape Stromal and Immune Bone Marrow Microenvironment (2019) (2)
- T-29 Early NK cell activation predicts successful treatment outcome in chronic HCV infection (2011) (2)
- PROSPECTIVE STUDY OF DYSPLASTIC NODULES IN CIRRHOSIS: CORRELATION WITH CT VASCULAR PATTERN, HISTOLOGY AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (2009) (2)
- T-11 5-year entecavir in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety but no prevention of HCC (2013) (2)
- 916 ENTECAVIR IS AN EFFECTIVE TREATMENT FOR NUC-NAIVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: 48-WEEK DATA FROM A LARGE MULTICENTER COHORT STUDY (2009) (2)
- IMPORTANCE OF NON‐H‐2 GENES IN THE CONTROL OF THE IN VIVO GROWTH OF THE VIRUS INDUCED LYMPHOMA YC8 (1981) (2)
- 602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPY (2009) (2)
- Tumor and dendritic cells as cellular vaccines: confrontation and perspectives – a symposium in writing (1998) (2)
- 934 DIFFERENCES IN HCV GENOTYPE 1 RVR RATES AMONG CLINICAL TRIALS IN EUROPE DEPEND ON HCV RNA ASSAY SENSITIVITY (2012) (2)
- Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: The german telaprevir early access program (2013) (2)
- OC.03.2 ENTECAVIR FOR NUC-NAÏVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: LONG-TERM EFFECTIVENESS FROM A LARGE MULTICENTER COHORT STUDY IN 376 PATIENTS (2010) (2)
- Oligodeoxynucleotides in Mice Antitumor Activity Induced by CpG Absence of the CD1 Molecule Up-Regulates (2002) (2)
- Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timing (2021) (2)
- Successful treatment of hepatocellular carcinoma with transcatheter arterial embolization (TAE) with microspheres (Embosphere) (2006) (2)
- P.1.29: A SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON PREVENTS INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS (2011) (2)
- Conference on cancer vaccines (2000) (2)
- Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells. (1991) (2)
- Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC (2022) (2)
- Presentation of tumor antigens. The role of dendritic cells (1999) (2)
- O.064 Antiviral treatment for hepatitis C virus infection in the real practice: A nationwide Italian experience (the PROBE study) (2006) (2)
- 15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208 (2010) (2)
- T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models (2021) (2)
- Low probability of major liver related events in chronic hepatitis delta (2005) (2)
- [566] PRE-TREATMENT FACTORS PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN TREATMENT-NAIVE HCV GENOTYPE 1 PATIENTS PARTICIPATING IN A LARGE, PRACTICE-BASED NATIONWIDE OBSERVATIONAL STUDY (2007) (2)
- Abstract 4480: Circulating and tumor associated neutrophil subtypes correlate with hyperprogressive disease (HPD) upon immunecheckpoint inhibitors (ICI) in advanced non-small cell lung cancer (aNSCLC) patients (pts) andin vivomodels (2020) (1)
- 753 NUCLEOS(T)IDE ANALOGUES CAN BE SAFELY DISCONTINUED IN CHRONIC HEPATITIS B PATIENTS ACHIEVING HBSAG SEROCLEARANCE (2011) (1)
- Efficacy and safety of pegylated interferon plus ribavirin in patients with hepatitis C recurrence after liver transplantation: A single centre experience (2007) (1)
- Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction? (2022) (1)
- P.03.3 TRANSIENT ELASTOGRAPHY IN CELIAC PATIENTS: A NON INVASIVE METHOD TO DETECT LIVER INVOLVEMENT ASSOCIATED TO CELIAC DISEASE (2012) (1)
- Abstract A102: Osteopontin produced by myeloid cells determines the outcome of breast cancer metastases (2013) (1)
- Multimodal and sequential treatment for hepatocellular carcinoma: How “real-life” complies with international recommendations (2018) (1)
- F-05 Clinical implications of baseline population sequencing of the NS3 protease in HCV-1 partial or null-responders to Peg-interferon/ribavirin (2013) (1)
- Progression through Multiple Oncogenic Mechanisms MicroRNA-221 /-222 Pathway Controls Melanoma − The Promyelocytic Leukemia Zinc Finger (2008) (1)
- OC.03.3 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY (2010) (1)
- Chronic hepatitis C (CH-C) genotype 1: An independent, multicenter RCT comparing PEG-IFN ALFA-2B 12KD plus ribavirin (RBV) and IFN ALFA-2B plus (RBV) in naive patients (2003) (1)
- ACQUIRED DISEASES RESEARCH ARTICLE In vivo correction of genetic defects of monocyte/ macrophages using attenuated Salmonella as oral vectors for targeted gene delivery (2000) (1)
- Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling (2022) (1)
- Lymphocyte-Endothelial Cell Cross-Talk and Angiogenesis Depends on IL-12 Inhibition of Endothelial Cell Functions (2001) (1)
- P.04.5 THE COURSE OF BONE MINERAL DENSITY IN PATIENTS WITH CHRONIC HEPATITIS B LONG TERM TREATED WITH NUCLEOS(T)IDE ANALOGS: A LONGITUDINAL COHORT STUDY (2012) (1)
- Refined localization of H7 and Ctt1 on distal mouse chromosome 9 (2004) (1)
- Abnormal expression of histocompatibility antigens on cancer cells. (1982) (1)
- Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer. (2022) (1)
- 420 TRANSIENT ELASTOGRAPHY EARLY PREDICTS PROGRESSIVE RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2010) (1)
- Up-Regulation of Immune Tolerance Genes in Leukemic Mesenchymal Stromal Cells Is Induced By Acute Myeloid Leukemia Cells through an IFN-Gamma-Dependent Inflammatory Signaling (2018) (1)
- Safety of Simeprevir-Based Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Observational Study (2016) (1)
- 794 PROSPECTIVE STUDY OF DYSPLASTIC NODULES IN CIRRHOSIS: CORRELATION WITH CT VASCULAR PATTERN, HISTOLOGY AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (2009) (1)
- 389 LOW RISK OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A 3-YEAR FOLLOW-UP STUDY IN 78 PATIENTS WITH CHRONIC HEPATITIS B (2008) (1)
- Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT). (2017) (1)
- 716 PROGNOSTIC GENE-EXPRESSION SIGNATURE FOR HEPATITIS C-RELATED EARLY-STAGE LIVER CIRRHOSIS (2012) (1)
- Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. (2018) (1)
- 769 GENOTYPE DEPENDENT PATTERN OF PEGINTERFERON ALFA-2B/RIBAVIRIN TREATMENT FAILURE IN HEPATITIS C VIRUS INFECTED PATIENTS WITH CIRRHOSIS: A SINGLE CENTER STUDY OF 471 NAIVE PATIENTS (2008) (1)
- 425 IL28B GENOTYPE IN HDV CHRONIC PATIENTS CORRELATES WITH UNFAVOURABLE OUTCOME BUT NOT WITH RESPONSE TO IFN TREATMENT (2013) (1)
- 912 PROGRESSIVE DECLINE OF HBsAg TITERS IN LONG- TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B (2009) (1)
- OC-21 The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR (2012) (1)
- Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B (2005) (1)
- CYTOKINE BASED TUMOR IMMUNOTHERAPY (1998) (1)
- immune reactivity mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses Myeloid cell expansion elicited by the progression of spontaneous (2013) (1)
- Abstract 2877: Dual role of mast cells in prostate tumors. (2013) (1)
- F-35 Nucleos(t)ide analogues can be safely discontinued in chronic hepatitis B patients achieving HBsAg seroclearance (2011) (1)
- Neutrophils discriminate between G-CSF producing and non-producing colon carcinoma cells: correlation with tumor inhibition (1991) (1)
- CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions (2021) (1)
- Transduction of MHC-class I negative allogeneic cell line to improve the efficacy of anti-tumor vaccination. (2002) (1)
- P1059 PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGS (2014) (1)
- Antitumor Resistance Macrophages Inhibits M 1 Inflammatory Responses and B Overexpression in Tumor-Associated κ p 50 Nuclear Factor-Updated (2006) (1)
- Regulatory T Cells in Cancer (2008) (1)
- 27 Rescue treatment with adefovir dipivoxil for lamivudine resistant patients pre- and post- liver transplantation (2003) (1)
- Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy (2021) (1)
- OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer. (2015) (1)
- T-regulatory cells in Crohn's disease patients treated with infliximab (2008) (1)
- 722 LIVER STIFFNESS AND HEPATOCELLULAR CARCINOMA: IS IT REALLY USEFUL? (2013) (1)
- OC-30 Incidence and clinical consequences of reduced tubular phosphate re-absorption in naïve CHB patients treated with tenofovir: a two-year field study (2013) (1)
- High rates of tenofovir dose adjustments are required in Adefovir experienced patients with chronic hepatitis B: A 4-year prospective study in 320 patients (2014) (1)
- Biased stroma in the autoimmunity-lymphoma transition (2013) (1)
- 259 DETERMINANTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB (2013) (0)
- Eradication of a disseminated BALB/c mice lymphoma by adoptive transfer of syngeneic anti-DBA/2 T lymphocytes does not require the partecipation of radiation-sensitive host cells (1985) (0)
- Mechanisms of Tolerance Induction through T Regulatory Cells during Chemotherapy-Mediated Immunogenic Cell Death in Acute Myeloid Leukemia (2019) (0)
- 1148 THE PRESENCE OF HEPATITIS C VIRUS DELETION MUTANTS IN CHRONIC HEPATITIS C PATIENTS AND THEIR ROLE DURING PEG-IFN/RIBAVIRIN THERAPY IN HCV-1 PATIENTS (2011) (0)
- ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2A IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY (2009) (0)
- Isolation of differentially expressed genes related with ham saltino loss in Italian heavy pig (2005) (0)
- P.09.14 FEASIBILITY AND REPRODUCIBILITY OF NON-INVASIVE LIVER AND PANCREATIC STIFFNESS ASSESSMENT IN A COHORT OF PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE (2018) (0)
- 768 LOW RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH CHRONIC HEPATITIS C AND CONCURRENT INACTIVE HEPATITIS B INFECTION TREATED WITH INTERFERON AND RIBAVIRIN (2008) (0)
- P.132 CHEMOEMBOLIZATION WITH EPIRUBICIN DRUG ELUTING BEADS TO TREAT EARLY AND INTERMEDIATE HEPATOCELLULAR CARCINOMA (2010) (0)
- 441 Hepatocellular carcinoma associated to chronic hepatitis delta (2004) (0)
- OPTIMISING CANCER IMMUNOTHERAPY : CHALLENGES AND OPPORTUNITIES Summary of Presentations from a prIME Oncology Scientific Exchange on 21 st May 2016 in Amsterdam , Netherlands (2016) (0)
- 1647TiP Antiandrogen therapy and TMPRSS2 status: How prostate cancer patients are protected from COVID-19 pandemic (2021) (0)
- [174] DETECTION OF AUTOANTIBODIES AGAINST CYTOCHROME P450 2E1 (CYP2E1) IN PATIENTS WITH RECURRENT HEPATITIS C (2007) (0)
- Molecular and Cellular Pathobiology Inhibiting Interactions of Lysine Demethylase LSD 1 with Snail / Slug Blocks Cancer Cell Invasion (2012) (0)
- P.1.317: ACUTE ALCOHOLIC HEPATITIS AND TRANSIENT ELASTOGRAPHY: OVERESTIMATION OF LIVER FIBROSIS RELATED TO LIVER CELL INFLAMMATION (2011) (0)
- Abstract SY35-02: Bone marrow remodeling in response to distant tumor starts early in transformation (2019) (0)
- OC-31 Low rates of SVR to peg-interferon plus ribavirin in HCV genotype 1 IL28B rs12979860 CC cirrhotic patients without rapid virological response (2012) (0)
- 169PNeoadjuvant eribulin following anthracycline and taxane in triple negative breast cancer (HOPE): A multicenter, two stage, phase II trial (2017) (0)
- 303 EARLY ACTIVATION OF EFFECTOR CYTOTOXIC NK CELLS PREDICTS SUCCESSFUL TREATMENT OUTCOME IN CHRONIC HCV INFECTION (2011) (0)
- F-17 Serum HBsAg decline is faster than previously estimated in long-term NUC responders with low treatment-induced HBsAg levels (2013) (0)
- Abstract 3526: The transcription factor ZEB1 shapes osteosarcoma aggressiveness by affecting tumor cell differentiation and stemness features (2023) (0)
- Abstract 5506: Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations (2023) (0)
- Anti-IgE vaccination prevents human IgE-mediated severe anaphylaxis in humanized mice (2021) (0)
- P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY (2014) (0)
- Mesenchymal Transition o f High-Grade Breast CarcinomasDepends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity Graphical (0)
- 251 Increased expression of vascular endothelial growth factor and its receptor in hepatocellular carcinoma and extra-tumoral cirrhotic tissues (2004) (0)
- BBR 3576 a 9-aza-anthrapyrazole endowed with high antitumor activity on prostate carcinoma models (2007) (0)
- 15 First-line platinum-based chemotherapy combined with PD-1/PD-L1 inhibitors (ICI) prevents hyperprogression in non-small cell lung cancer (NSCLC) patients by reducing circulating immature neutrophils (2021) (0)
- Oral CommunicationsA SEQUENTIAL PREDICTIVE ALGORITHM COMBINING APRI AND TRANSIENT ELASTOGRAPHY (TE) FOR DIAGNOSING LIVER FIBROSIS IN CHRONIC HEPATITIS C (2009) (0)
- T-40 Clinical and economic impact of the updated AASLD criteria for the diagnosis of hepatocellular carcinoma (HCC) (2013) (0)
- Snail / Slug-LSD 1 interaction inhibition and invasion arrest 1 Inhibiting interactions of lysine demethylase LSD 1 with Snail / Slug blocks cancer cell invasion Running Title : Inhibition of Snail / Slug-LSD 1 interaction and invasion (2012) (0)
- T-41 Accuracy of [18F]fluorocholine (18F-FCH) PET/CT for the characterization of de novo liver nodules detected in cirrhotic patients: aprospective pilot study (2013) (0)
- 983 Steatosis is a cofactor for fibrosis and response to therapy in genotype 1B chronic hepatitis C (CHC) (2003) (0)
- 1065 COMBINED TRANSIENT ELASTOGRAPHY OF THE LIVER AND SPLEEN TO ASSESS DISEASE SEVERITY IN CHRONIC VIRAL LIVER DISEASE (2012) (0)
- S28 T-regulatory cells in Crohn's disease patients treated with infliximab (2010) (0)
- Lack of Improvement of Liver Stiffness during Sofosbuvir-Treatment in Decompensated Cirrhotic Patients Listed for Liver Transplant Seems to be Associated with more Severe Histological Damage in the Native Liver (2016) (0)
- Abstract 1669: Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts) (2021) (0)
- 25P Platinum-based chemotherapy (PCT) addition to first-line PD-1/PD-L1 inhibitors (ICI) prevent hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) patients (pts) by reducing circulating immature neutrophils (2022) (0)
- Upon Adoptive Transfer Lymphocytes That Cure Lung Metastases Induces Immunoregulatory Type 2 CD 8 T IL-4-Transduced Tumor Cell Vaccine (1999) (0)
- Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5–7, 2012 (2013) (0)
- P.103 No evidence for ADV resistance in HBeAg-negative lamivudine resistant patients treated with lamivudine-adefovir combination for 3 years (2006) (0)
- Diagnostic accuracy and standardization of fine needle biopsy in the characterization of liver nodules in cirrhosis. (2010) (0)
- 2013 POSTER Bone marrow-derived TNF-a promotes tumour growth in a spontaneous model of mammary carcinogenesis (2007) (0)
- MA04.06 PD-1 Blockade Promotes Hyperprogressive Disease in NSCLC Through Macrophages Activation via Antibody-Fc/FcR Interaction (2018) (0)
- IgG 2 a Induced by Interleukin ( IL ) 12-producing Tumor Cell Vaccines but not IgGl Induced by IL-4 Vaccine Is Associated with the Eradication of Experimental MÃ © tastases 1 (2006) (0)
- Extra-hepatic tumor recurrence after directly-acting-antiviral (DAA) therapy in HCV patients (2019) (0)
- OC-9 The presence of hepatitis C virus deletion mutants in chronic hepatitis C patients and their role during PEG-IFN/ribavirin therapy (2011) (0)
- F-08 IL28B genotype is not associated with insulin resistance in chronic hepatitis C patients (2013) (0)
- F-13 Switching to tenofovir is safe in most CHB patients with a reduced glomerular filtration rate due to previous exposure to adefovir dipivoxil (2013) (0)
- Transient elastography (TE) detects graft damage in liver transplanted (LT) patients with aetiologies other than HCV (2008) (0)
- 1072 A five-year cohort study of patients with dual infection with HBV and HCV (2003) (0)
- Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timing (2021) (0)
- Contributes to Mammary Carcinogenesis Production of Tumor Necrosis Factor That Critically Oncogene-Driven Intrinsic Inflammation Induces Leukocyte (2010) (0)
- 31 Salivary glands impairment during interferon/ribavirin treatment in patients with chronic hepatitis C (2003) (0)
- cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells (2018) (0)
- P.18.16 HEPATIC AND SPLENIC STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY: FEASIBILITY AND POSSIBLE ROLE IN PATIENTS WITH HEMOGLOBINOPATHIES (2013) (0)
- Leukemic Transformation Induces the Constitutive Expression of Indoleamine 2,3-Dyoxigenase Which Directly Increases CD4+CD25+ T Regulatory Cells. (2005) (0)
- T-17 Sustained virologic response to interferon prevents the lethal consequence of clinical decompensation in patients who develop a hepatocellular carcinoma post antiviral-treatment (2012) (0)
- 477 High rates of hepatitis B virus reverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation (2006) (0)
- Constitutive expression of HOXB7 causes stem cell proliferation and myeloid-restricted differentiation (1997) (0)
- JMJD6 shapes a pro-tumor microenvironment via ANXA1-dependent macrophage polarization in breast cancer. (2023) (0)
- The Role of Cytokines in Antitumor Immune Response: From Detection to Gene Therapy (1993) (0)
- Precursors to Enhance Antigen Uptake and Targets Immature Dendritic Cell Tumor Cell Killing Induces Th1 Cytokines Heat Shock Protein 70 Induced During (1999) (0)
- P.04.10 THE ROLE OF HEPATIC AND SPLEEN STIFFNESS IN THE ASSESSMENT OF DISEASE SEVERITY IN CHRONIC VIRAL HEPATITIS (2012) (0)
- P992 FIRST-LINE TREATMENT OF 90 CONSECUTIVE HCC WITH DRUG ELUTING BEADS CHEMOEMBOLIZATION (DEB-TACE) (2014) (0)
- In vitro detection of cell-mediated immunity to individual tumor-specific antigens of methylcholanthrene induced balb/c fibrosarcomas. Abstr. (1983) (0)
- Abstract 2556: The protective role of mast cells against neuroendocrine prostate cancer depends on the release of cytokines mediated by intracellular osteopontin (2022) (0)
- P965 PERSONALIZED THERAPY WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA (2014) (0)
- 1008 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON PREVENTS THE LETHAL CONSEQUENCE OF CLINICAL DECOMPENSATION IN PATIENTS WHO DEVELOP A HEPATOCELLULAR CARCINOMA POST ANTIVIRAL-TREATMENT (2012) (0)
- Serum nuclear autoantibodies with nucleolar pattern in chronic liver diseases (2006) (0)
- Genotype 3 infection in DAA era: Preliminary reports of a real life northern Italy network for viral hepatitis (2016) (0)
- P1035 LIVER (LS) AND SPLEEN STIFFNESS (SS) IN PATIENTS WITH HAEMOGLOBINOPATHIES. DATA FROM TRANSIENT ELASTOGRAPHY (TE) (2014) (0)
- T-46 Determinants of bleeding from esophageal varices in patients with advanced hepatocellular carcinoma treated with sorafenib (2013) (0)
- OC-31 The outcome of chronic hepatitis D is predicted by the levels of HDV viremia (2013) (0)
- PF576 NONSENSE-MEDIATED MRNA DECAY IS A THERAPEUTIC TARGET IN MULTIPLE MYELOMA (2019) (0)
- Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis (2016) (0)
- T-08 Interplay between on-treatment predictors and donor/recipients IL28B in predicting SVR to pegIFN/ribavirin in HCV-1,4 liver transplant recipients (2013) (0)
- Abstract 2141: Stromal SPARC deficiency skews prostate cancer toward neuroendocrine differentiation (2018) (0)
- Interferon (cid:103) –independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4 (cid:49) T Cells and Granulocyte/Macrophage Colony–stimulating Factor (1998) (0)
- OC.03.6 FIELD PRACTICE WITH SORAFENIB IN ADVANCED HCC: EFFECTIVENESS CONFIRMED, TOLERABILITY REDUCED BUT USUALLY MANAGEABLE, COMPARED TO REGISTRATION TRIALS (2010) (0)
- Immunizing potential of cytokine-transduced tumor cells. (2000) (0)
- MEF2C and SOCS2 in stemness regulation (2015) (0)
- Chemotherapy-Dependent ATP Release from Leukemia Dying Cells Induces Indoleamine 2,3-Dioxygenase 1 in Dendritic Cells (2016) (0)
- O123 POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT (2014) (0)
- 426 SERUM LEVELS OF HBsAg AND HBVDNA ARE NOT ASSOCIATED TO CLINICAL OUTCOME IN PATIENTS WITH CHRONIC HDV INFECTION (2013) (0)
- Carcinomas in Transgenic BALB/c Mice Carcinogenesis Than Transplantable p185 More Effectively Inhibits DNA Vaccination Against Rat Her-2/Neu (2000) (0)
- Minimal increases of alpha-fetoprotein above the normal value strongly predict HCC development in compensated Caucasian HBV cirrhotics treated by entecavir or tenofovir: a 7-year longitudinal cohort study in 225 patients (2017) (0)
- Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirintreatment in chronic hepatitis C (2011) (0)
- When Failure Is Worse Than Giving Up: The Case of CTL. (2019) (0)
- LYMPHOID NEOPLASIA Bone marrow stroma CD40 expression correlates with in fl ammatory mast cell in fi ltration and disease progression in splenic marginal zone lymphoma (2014) (0)
- Role of PD-L1 expression in triple-negative breast cancer stem cells. (2018) (0)
- Cancer immunity and immunotherapy beyond COVID-19 (2023) (0)
- P.134 DIAGNOSTIC YIELD AND STANDARDIZATION OF FINE NEEDLE BIOPSY IN THE CHARACTERIZATION OF LIVER NODULES IN CIRRHOTIC PATIENTS (2010) (0)
- F-9 The I148M PNPLA3 polymorphism is associated with the clinical presentation and prognosis of hepatocellular carcinoma (2012) (0)
- Alloimmunization-induced syngeneic antitumor immunity in balb/c mice. Abstr. (1982) (0)
- B7.1 PROVIDES A STRONG COSTIMULATORY SIGNAL FOR AUTOLOGOUS T-CELLS IN RECOGNIZING HUMAN OVARIAN CANCER CELLS (1997) (0)
- 110 No recurrence in patients transplanted for YMDD genotypic mutations using pre-emptive lamivudine followed by combination prophylaxis (2004) (0)
- Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020 (2022) (0)
- Is Treg plasticity the Achilles’ heel to their functional inactivation? (2011) (0)
- Accuracy of the Radiological Diagnosis of Hepatocellular Carcinoma outside the Periodic Surveillance with Ultrasound (2016) (0)
- Active immunization of melanoma patients with IL-2-OR IL-4-transduced allogeneic melanoma cells (1997) (0)
- 997 Active immunization of melanoma patients with IL-2-transfected allogeneic melanoma cells. A phase I-II study (1995) (0)
- P586 APPEARANCE OF COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA IN CIRRHOSIS AT CONTRAST ENHANCED IMAGING TECHNIQUES (2014) (0)
- Editors' viewpoint - Response (2014) (0)
- Abstract B157: OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer (2016) (0)
- Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement (2023) (0)
- Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7–9, 2010 (2011) (0)
- Multimodal and sequential treatmente for hepatocellular carcinoma: how “real-life” complies with international recommendations (2018) (0)
- Polygenic control of the in vivo immunity to balb/c sarcomas and lymphomas. Abstr. (1980) (0)
- 283 INDEPENDENT PREDICTORS OF DISCORDANCE BETWEEN TRANSIENT ELASTOGRAPHY (TE) AND LIVER BIOPSY (LB) (2008) (0)
- 1099 ITPA VARIANTS PREDICT TREATMENT-INDUCED ANEMIA AND THE NEED FOR RIBAVIRIN DOSE REDUCTION AND ERYTHROPOIETIN SUPPORT (2012) (0)
- Transduction of protectin (CD59) enhances the resistance of human melanomas to homologous CDC (1998) (0)
- The natural history of hepatic macroregenerative nodules developing in cirrhotic patients during surveillance with ultrasound. (2010) (0)
- ITPA deficiency does not predict anaemia during Ribavirin containing DAA all oral regimens for HCV (2016) (0)
- Microenvironment and Immunology Osteopontin Shapes Immunosuppression in the Metastatic Niche (2014) (0)
- 588 DIAGNOSTIC VALUE OF LENS CULINARIS AGGLUTININ ISOFORM 3 (AFP-L3) AND DES-GAMMA-CARBOXY PROTHROMBIN (DCP) FOR THE DIAGNOSIS OF HCC IN CIRRHOTIC PATIENTS (2010) (0)
- Genetic Unresponsiveness to a Murine Fibrosarcoma Determined by the Host Genetic Environment but not by Lymphocyte Precursor Genotype (1985) (0)
- Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008 (2009) (0)
- Serum Markers for early diagnosis of hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virological response to direct-acting antivirals treatment (2017) (0)
- Comparison of field practice to registration trials of sorafenib in advanced HCC for effectiveness and tolerability. (2010) (0)
- CS3.3 INDEPENDENT PREDICTORS OF DISCORDANCE BETWEEN TRANSIENT ELASTOGRAPHY (TE) AND LIVER BIOPSY (2008) (0)
- 810 INTERPLAY BETWEEN ON-TREATMENT PREDICTORS AND DONOR/RECIPIENT (D/R) IL28B STATUS IN PREDICTING SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV-1,4 LIVER TRANSPLANT (LT) RECIPIENTS TREATED WITH PEG-INTERFERON+ RIBAVIRIN (PR) (2013) (0)
- P.051 Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation (2006) (0)
- OC-1 Prospective Italian multicenter field-practice study with sorafenib for advanced hepatocellular carcinoma (2011) (0)
- Core Antigen Quantification to Monitor Treatment Efficacy in Patients with Chronic Hepatitis C Receiving Directly Acting Antivirals (2016) (0)
- Abstract A24: Bone marrow hematopoietic adaptation as a sensor of early, pre-invasive, epithelial malignancy (2018) (0)
- ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation (2022) (0)
- Serum autoantibodies correlates with severity of hepatitis C recurrence after liver transplant (2006) (0)
- PA.103 LOW RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH CHRONIC HEPATITIS C AND CONCURRENT INACTIVE HEPATITIS B INFECTION TREATED WITH INTERFERON AND RIBAVIRIN (2008) (0)
- 187 INDEPENDENT INFLUENCERS OF TRANSIENT ELASTOGRAPHY ASSESSMENT OF LIVER FIBROSIS IN HEPATITIS B AND HEPATITIS C PATIENTS (2009) (0)
- Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO (2022) (0)
- 448 Rescue treatment with adefovir dipivoxil in lamivudine resistant patients with chronic hepatitis B (2004) (0)
- Bitter taste receptor genes in pigs: SNP identification by using next- generation semiconductor sequencing (2013) (0)
- 1057P Baseline circulating immature neutrophils anticipate hyperprogressive disease (HPD) upon 1st-line PD-1/PD-L1 inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients (pts) and are reduced by platinum-based chemotherapy (PCT) and ICI combinations (2022) (0)
- Competent B Cells - Differentiation of IL-10 Mast Cells Control the Expansion and (2014) (0)
- 975 Salivary glands impairment in patients with chronic hepatitis C undergoing PEG-interferon/ribavirin treatment (2003) (0)
- High rates of renal tubular damage in HBV monoinfected patients long-term treated with Tenofovir: a cross-sectional, single center, real-life study in 414 patients (2017) (0)
- Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19–22, 2011: New perspectives in the immunotherapy of cancer (2012) (0)
- Modulation of antigen presenting cells-tumor cells interactions (1999) (0)
- The Induction of Inhibitory Pathways in Dendritic Cells May Hamper the Efficient Activation of Anti-Leukemia T Cells within Chemotherapy-Induced Immunogenic Cell Death (2015) (0)
- Interleukin-12 Gene Expression into Acute Myeloid Leukemia-Derived Dendritic Cells Overcomes T-Cell Functional Impairment Induced by Leukemic Microenvironment. (2004) (0)
- PA.102 VERY EARLY ADD-ON ADEFOVIR THERAPY IN PATIENTS WITH SUB-OPTIMAL VIROLOGICAL RESPONSE TO LAMIVUDINE (2008) (0)
- Low diagnostic accuracy of the AASLD radiologic criteria for hepatocellular carcinoma in grade I tumors. (2010) (0)
- T-17 Add-on Peg-IFN improves HBsAg kinetics in HBeAg-negative patients long-term fully suppressed by nucleos(t)ide analogs (2013) (0)
- CS.2.4 CONTRAST IMAGING TECHNIQUES CORRELATE WITH TUMOR GRADING IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE (2010) (0)
- Mast cells and immune response in cancer (2014) (0)
- P744 DEPDC5 GENE LOCUS ASSOCIATES WITH SEVERE LIVER FIBROSIS IN INDIVIDUALS WITH CHRONIC HCV INFECTION (2014) (0)
- Perspectives in Cancer Research Immunoprevention of Cancer : Is the Time Ripe ? 1 (2000) (0)
- Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy (2020) (0)
- Inosine Triphosphatase Deficiency does not Predict Anaemia during Ribavirin Containing DAA All Oral Regimens for HCV (2016) (0)
- 190 GRAFT DYSFUNCTION (GD) IN HBV RECURRENCEFREE RECIPIENTS IS ASSOCIATED WITH SERUM AUTOANTIBODIES REACTIVITY (2008) (0)
- Genotypic analysis of YMDD locus of HBV in patients responding to lamivudine monotherapy (2003) (0)
- A TaqI RFLP at the gas-2 locus. (1989) (0)
- OC-7 NK profiles of non-responder and relapser patients with cHCV infection treated with SOC (2012) (0)
- Interferon g – independent Rejection of Interleukin 12 – transduced Carcinoma Cells Requires CD 4 1 T Cells and Granulocyte / Macrophage Colony – stimulating Factor (2010) (0)
- PA.106 HEPATITIS C VIRUS GENOTYPES AND PATTERNS OF PEGINTERFERON ALFA-2B/RIBAVIRIN TREATMENT FAILURE IN PATIENTS WITH CIRRHOSIS: A SINGLE CENTER STUDY OF 471 NAÏVE PATIENTS (2008) (0)
- P1212 USE OF BASELINE FIBROSCAN TO PREDICT EFFICACY AND SAFETY OF TREATMENT FOR 1143 PATIENTS IN THE TELAPREVIR EARLY ACCESS PROGRAMME (2014) (0)
- Healthy and tumoral tissue resistivity in wild-type and sparc–/– animal models (2016) (0)
- 594 ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2a IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY (2009) (0)
- Regulation and effect of TNFβ expression in melanoma cell lines: 283 (1993) (0)
- P187 INNATE ANTIVIRAL RESPONSES IN HBeAg NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CH-B) UNDER LONG-TERM NUCLEOS(T)IDE ANALOGUE (NUC) TREATMENT: IMPLICATIONS FOR FUTURE IMMUNE THERAPIES (2014) (0)
- F-5 Prospective validation of 2010 AASLD guideline for the diagnosis of 1-2 cm HCC in cirrhotic patients (2012) (0)
- Serum antinuclear antibodies (ANA) in HCV-related cirrhosis: Correlation with liver cell proliferation status and hepatocellular carcinoma (HCC) development (2006) (0)
- 448 IL28B GENOTYPE IS NOT ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS (2013) (0)
- 229 NATURAL HISTORY AND MULTIMODALITY TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA PROSPECTIVELY DETECTED IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE (2010) (0)
- P.133 DIAGNOSTIC VALUE OF LENS CULINARIS AGGLUTININ ISOFORM 3 FRACTION (AFP-L3%) AND DES-GAMMA-CARBOXY PROTHROMBIN (DCP) FOR THE DIAGNOSIS OF HCC IN CIRRHOTIC PATIENTS (2010) (0)
- Notch pathway promotes multiple myeloma cell IL-6 independence (2014) (0)
- Acute and Late Mast Cell Responses The Aryl Hydrocarbon Receptor Modulates (2012) (0)
- Author response for "IL‐10‐producing B cells are characterized by a specific methylation signature" (2019) (0)
- P.162 TRANSIENT ELASTOGRAPHY EARLY PREDICTS PROGRESSIVE RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2010) (0)
- Search of candidate genes for salting loss of ham by using Fluoro Differential Display (FDD) (2005) (0)
- Evaluation of osteonectin as a marker of the osteoblastic lineage in bone tumors (1991) (0)
- Evaluating liver fibrosis in chronic hepatitis c (CHC), accuracy of two new predictive models (2006) (0)
- OC3.04.6 LIVER CELL PROLIFERATION AND LIVER CANCER RISK IN PATIENTS WITH HEPATITIS C VIRUS-RELATED CIRRHOSIS UNDER ANTIVIRAL TREATMENT (2008) (0)
- P271 INTERACTION BETWEEN DIETARY FACTORS AND INSULIN RESISTANCE IN THE PATHOGENESIS OF NONALCOHOLIC STEATOHEPATITIS (2014) (0)
- 1080 LOW RATES OF SVR TO PEGINTERFERON PLUS RIBAVIRIN IN HCV GENOTYPE 1 IL28B RS12979860 CC CIRRHOTIC PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE (2012) (0)
- Role of the carbohydrate prosthetic groups in the biosynthesis of membrane antigens and in the H-2-restricted lysis of MBL-2 lymphoma cells. (1983) (0)
- T-16 Contrast-enhanced CT scan differentiates hepatocellular carcinoma and intrahepatic cholangiocarcinoma in cirrhosis (2012) (0)
- Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity. (1987) (0)
- P.1.95: DUAL CUT-OFF ELASTOGRAPHY TO ASSESS LIVER FIBROSIS IN CHRONIC HEPATITIS B: A COHORT STUDY WITH INTERNAL VALIDATION (2011) (0)
- Abstracts selected for oral presentation: EMBRN webinar March 3rd 2021 1 1 Inotodiol ameliorates Th2 mediated airway inflammation by attenuating mast cell activities in a mouse model of asthma (2021) (0)
- F-36 Transarterial chemoembolization with drug-eluting beads (DEB TACE) for BCLC-A hepatocellular carcinoma (HCC): a radical option? (2013) (0)
- 35 Preclinical model for gene therapy: Role of the host (1995) (0)
- TM6SF2, MBOAT7 and PNPLA3 genotypes in patients with untreated HCV chronic hepatitis and alcohol intake (2017) (0)
- P658 LOW RISK OF HEPATITIS B VIRUS REACTIVATION IN HBsAg NEGATIVE, ANTI-HBc POSITIVE CARRIERS UNDERGOING RITUXIMAB FOR RHEUMATOID ARTHRITIS (2014) (0)
- 46 IMMUNOLOGICAL PROFILES OF NON-RESPONDER AND RELAPSER PATIENTS WITH CHRONIC HCV INFECTION TREATED WITH STANDARD OF CARE THERAPY (2012) (0)
- 35 THE NATURAL HISTORY OF HEPATIC MACROREGENERATIVE NODULES DEVELOPING IN CIRRHOTIC PATIENTS DURING SURVEILLANCE WITH ULTRASOUND (US) (2010) (0)
- P991 CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA WITH M1 DRUG ELUTING BEADS: SAFETY AND EFFECTIVENESS (2014) (0)
- 1066 LIVER STIFFNESS IN A SERIES OF CELIAC PATIENTS (2012) (0)
- HEPATOCELLULAR CARCINOMA ASSOCIATED TO CHRONIC HEPATITIS DELTA (2009) (0)
- This information is current as Host T Cell Antitumor Response Requires CD40-Apc Signaling to Boost the Vaccine Synergizes with GM-CSF and OX40 Ligand-Transduced Tumor Cell (2013) (0)
- Cytokine gene-transduced tumor cells in cancer therapy: Tumor inhibition by non-specific and specific immune mechanisms (1993) (0)
- Liver, Pancreas and Biliary Tract N association of HLA-haplotypes with primary sclerosing q cholangitis (PSC) in a southern European population (2003) (0)
- 117 PROSPECTIVE STUDY OF NK CELL PHENOTYPE IN RECURRENT HCV INFECTION AFTER LIVER TRANSPLANT (2008) (0)
- T-18 Liver follicular helper T-cells in chronic hepatitis C (2011) (0)
- P.140 NATURAL HISTORY AND MULTIMODALITY TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA PROSPECTIVELY DETECTED IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE (2010) (0)
- Bystander secretion of hsp70 provides adjuvant effect throughout DC-NK interaction (2005) (0)
- Natural history and multimodality treatment of early hepatocellular carcinoma prospectively detected in cirrhotic patients under surveillance. (2010) (0)
- Prognostic role of CD73 in metastatic non small cell lung cancer according to the presence of driver alterations (2019) (0)
- P33.01 Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC (2021) (0)
- Temporal trends of access to DAAs treatments for HCV in the Navigatore-Lombardia network: Evolution of AIFA criteria, DAA regimens and patient features (2018) (0)
- Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy (2021) (0)
- Moloney murine leukemia virus encodes a non h 2 histocompatibility antigen in viremic mov strains (1988) (0)
- Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis (2017) (0)
- Intra-tumor heterogeneity of Diffuse Large B-cell Lymphoma involves the induction of diversified stroma-tumor interfaces (2020) (0)
- Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of liver graft hepatitis C recurrence (2007) (0)
- 194 THE NATURAL HISTORY OF HEPATIC MACROREGENERATIVE NODULES DEVELOPING IN CIRRHOTIC PATIENTS DURING SURVEILLANCE WITH ULTRASOUND (2010) (0)
- 587 DIAGNOSTIC YIELD AND STANDARDIZATION OF FINE NEEDLE BIOPSY IN THE CHARACTERIZATION OF LIVER NODULES IN CIRRHOTIC PATIENTS (2010) (0)
- 746 PROSPECTIVE VALIDATION OF 2010 AASLD GUIDELINE FOR THE DIAGNOSIS OF 1-2 CM HCC IN CIRRHOTIC PATIENTS (2012) (0)
- T-31 Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C (2012) (0)
- P1210 PREDICTORS OF SVR24 FOR 1078 PATIENTS WITH SEVERE FIBROSIS OR COMPENSATED CIRRHOSIS: THE INTERNATIONAL TELAPREVIR ACCESS PROGRAM (2014) (0)
- Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment (2018) (0)
- Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1–3 October 2009 (2010) (0)
- F-12 IL28B genotype in patients with chronic hepatitis delta (HDV) correlates with unfavourable outcome but not with response to IFN treatment (2013) (0)
- Abstract 4054: Mast cells contribute to T cell tolerance against prostate cancer- associated antigens favoring tumor growth (2015) (0)
- Transient elastography (TE) is an accurate tool in monitoring liver-transplanted (LT) patients with recurrent hepatitis C (2007) (0)
- Survival and risk factors associated with severe fibrosis in patients with recurrent hepatitis C (HepC-R) (2008) (0)
- Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer (2018) (0)
- 20 Liver expression of estrogen receptors alpha and beta correlates with aetiology and presentation of hepatocellular carcinoma (2003) (0)
- T.N.38 SAFETY AND EFFICACY OF PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND HIGH TITRES OF SERUM AUTOANTIBODIES: A SUB-ANALYSIS OF THE MIST STUDY (2010) (0)
- P.11.16 LIVER STIFFNESS AND HEPATOCELLULAR CARCINOMA: A SINGLE-CENTRE EXPERIENCE (2013) (0)
- Macrophage Infiltration in Tumor Stroma Myeloid-Derived Suppressor Cell Expansion and the Tumor-Bone Marrow Axis Responsible for Mediated MMP-9 Inhibition Breaks − Amino-Biphosphonate (2007) (0)
- T-36 Fibrosis progression in patients with chronic hepatitis C is not influenced by IL28B polymorphisms (2011) (0)
- myb That Express c-Oligodeoxynucleotides in Colon Adenocarcinoma Cell Lines Antisense myb Inhibition of Proliferation by c-Updated Version (2006) (0)
- T-37 Distribution of the IL28B rs12979860 polymorphism and its influence on sustained virological response rates in the MIST trial (2011) (0)
- P.15.15 Transient Elastography in Acute Alcoholic Hepatitis: Overestimation of the Fibrosis Due to Inflammation (2012) (0)
- CD40 provides immune privilege to the bone marrow hematopoietic niche (2020) (0)
- PC.01.1 MANAGEMENT OF BILIARY ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY): RESULTS OF A NATIONAL SURVEY IN ITALY (2016) (0)
- Hepatitis Delta prevalence and clinical expression in an immigrant population in Italy (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mario Paolo Colombo?
Mario Paolo Colombo is affiliated with the following schools: